Literature DB >> 3045249

Effects of T cell depletion in radiation bone marrow chimeras. II. Requirement for allogeneic T cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking of tolerance.

M Sykes1, M A Sheard, D H Sachs.   

Abstract

The ability of normal recipient-type lymphocytes to break tolerance in long-term allogenic radiation chimeras has been investigated. Reconstitution of lethally irradiated mice with a mixture of syngeneic and allogeneic T cell-depleted (TCD) bone marrow (BM) has previously been shown to lead to mixed chimerism and permanent, specific tolerance to donor and host alloantigen (3-5). If allogeneic T cells are not depleted from the reconstituting inoculum, complete allogeneic chimerism results; however, no clinical evidence for GVHD is observed, presumably due to the protective effect provided by syngeneic TCD BM. This model has now been used to study the effects of allogenic T cells administered in reconstituting BM inocula on stability of long-term tolerance. We have attempted to break tolerance in long-term chimeras originally reconstituted with TCD or non-TCD BM by challenging them with inocula containing normal, nontolerant recipient strain lymphocytes. tolerance was broken with remarkable ease in recipients of mixed marrow inocula in which both original BM components were TCD. In contrast, tolerance in chimeras originally reconstituted with non-TCD allogeneic BM was not affected by such inocula. Susceptibility to loss of chimerism and tolerance was not related to initial levels of chimerism per se, but rather to T cell depletion of allogeneic BM, since chimeras reconstituted with TCD allogeneic BM alone (mean level of allogeneic chimerism 98%) were as susceptible as mixed chimeras to the tolerance-breaking effects of such inocula. The possible contribution of GVH reactivity to this resistance was investigated using an F1 into parent strain combination. In these animals, the use of non-TCD F1 BM inocula for reconstitution did not lead to resistance to the tolerance-breaking effects of recipient strain splenocytes. These results suggest that the ability of T cells in allogeneic BM inocula to confer resistance to late graft failure may be related to their graft-vs.-host reactivity, even in situations in which they do not cause clinical GVHD. These findings may have relevance to the mechanism whereby T cell depletion of allogeneic BM leads to an increased incidence of late graft failure in clinical BM transplantation situations.

Entities:  

Mesh:

Year:  1988        PMID: 3045249      PMCID: PMC2188994          DOI: 10.1084/jem.168.2.661

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component.

Authors:  M Sykes; A Eisenthal; D H Sachs
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

2.  The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. II. Mouse spleen cell fractionation on a discontinuous albumin gradient.

Authors:  J I van Dicke KA Hooft; D W van Bekkum
Journal:  Transplantation       Date:  1968-07       Impact factor: 4.939

3.  Monoclonal anti-H-2Kb antibodies detect serological differences between H-2Kb mutants.

Authors:  L A Sherman; C P Randolph
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Fc (IgG) receptors on rat basophilic leukemia cells.

Authors:  D M Segal; S O Sharrow; J F Jones; R P Siraganian
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

5.  Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally and adoptively tolerized rats.

Authors:  S Dorsch; B Roser
Journal:  Transplantation       Date:  1982-05       Impact factor: 4.939

6.  Partial tolerance and immunity after adoptive abrogation of transplantation tolerance in the rat.

Authors:  W L Elkins; J S Adams; D H Fox; D B Wilson; F P Stuart
Journal:  Cell Immunol       Date:  1973-12       Impact factor: 4.868

7.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

8.  Protection of lethally irradiated mice by spleen cells from neonatally thymectomized mice.

Authors:  E J Yunis; R A Good; J Smith; O Stutman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

9.  Suppressor cells in transplantation tolerance. II. Identification and probable mode of action of chimeric suppressor T cells.

Authors:  S Dorsch; B Roser
Journal:  Transplantation       Date:  1982-05       Impact factor: 4.939

10.  Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells.

Authors:  A Singer; K S Hathcock; R J Hodes
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Tolerance induction for solid organ grafts with donor-derived hematopoietic reconstitution.

Authors:  K L Gandy
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool.

Authors:  Jianing Fu; Julien Zuber; Mercedes Martinez; Brittany Shonts; Aleksandar Obradovic; Hui Wang; Sai-Ping Lau; Amy Xia; Elizabeth E Waffarn; Kristjana Frangaj; Thomas M Savage; Michael T Simpson; Suxiao Yang; Xinzheng V Guo; Michelle Miron; Takashi Senda; Kortney Rogers; Adeeb Rahman; Siu-Hong Ho; Yufeng Shen; Adam Griesemer; Donna L Farber; Tomoaki Kato; Megan Sykes
Journal:  Cell Stem Cell       Date:  2018-11-29       Impact factor: 24.633

3.  Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions.

Authors:  Ronjon Chakraverty; Hyeon-Seok Eom; Jessica Sachs; Jennifer Buchli; Pete Cotter; Richard Hsu; Guiling Zhao; Megan Sykes
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

Review 4.  Stem cell transplantation for immunodeficiency.

Authors:  A Fischer; E Haddad; N Jabado; J L Casanova; S Blanche; F Le Deist; M Cavazzana-Calvo
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Visualization of immune response kinetics in full allogeneic chimeras.

Authors:  Gregory Elkin; Tatyana B Prigozhina; Shimon Slavin; Olga Gurevitch; Sofia Khitrin; Igor B Resnick
Journal:  Am J Blood Res       Date:  2011-08-22

Review 6.  Mechanisms of Mixed Chimerism-Based Transplant Tolerance.

Authors:  Julien Zuber; Megan Sykes
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

Review 7.  Hematopoietic stem cells and solid organ transplantation.

Authors:  Reza Elahimehr; Andrew T Scheinok; Dianne B McKay
Journal:  Transplant Rev (Orlando)       Date:  2016-08-03       Impact factor: 3.943

8.  Mouse xenoantigens contribute to rat T-cell Vbeta repertoire generation in mixed xenogeneic bone marrow chimeras.

Authors:  Y Huang; S T Ildstad; M Neipp; H Shirwan
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

9.  The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.

Authors:  Ronjon Chakraverty; Megan Sykes
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

10.  Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice.

Authors:  Yuqing Liu; Xiaoqi Wang; Yongping Zhu; Mingfeng Zhang; Ubaydah Nasri; Sharne S Sun; Stephen J Forman; Arthur D Riggs; Xi Zhang; Defu Zeng
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.